Funded Tech Companies
Adcendo
Operating out of Copenhagen, Adcendo has funding from Gilde Healthcare Partners, RA Capital Management and Healthcap Venture Capital.
Company Overview
Company Name
Adcendo
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
BioInnovation Institute, Ole Maaløes Vej 3, Copenhagen, Capi
Copenhagen, 2200
DK
Copenhagen, 2200
DK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Adcendo ApS is a Copenhagen-based biotech company dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. Antibody-drug conjugates (ADCs) represent an emerging drug modality, directing anticancer therapeutics to malignant cells overexpressing particular surface target molecules. 10+ ADCs are now in routine clinical use for cancer patients, with many more novel ADC assets currently investigated in clinical studies in solid tumors and hematologic malignancies
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/29/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Pehl
Chief Operating Officer
Christoffer Nielsen
Chief Scientific Officer
Dominik Mumberg
Chief Technical Officer
Pernille Hemmingsen
Company Investors
- Gilde Healthcare Partners
- RA Capital Management
- Healthcap Venture Capital
- Pontifax Venture Capital
- Dawn Biopharma (Iyona Rajkomar)
- Novo Holdings
- Ysios Capital
Browse more funded tech companies:
Adcade | Adcentrx Therapeutics
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs